MitoCareX Bio

Israel
Tel Aviv, Tel Aviv, Israel

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$1.1M
Last funding
Corporate Round / $400,000 / 2023-02-17
Last equity funding
Corporate Round / $400,000
Investors
1
Lead investors
1
Articles
19
Exited on
2025-02-26

Founders and investors

Lead investors

SciSparc

Investors

SciSparc